Phase 2 Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (any sex)
- You have been diagnosed with a type of cancer called malignant peritoneal mesothelioma (MPM) at the enrolling hospital
- During surgery, a tissue sample has confirmed your mesothelioma is the "epithelioid" type (a specific subtype)
- Surgeons were able to remove all or almost all of the cancer during your procedure
- You are planning to have surgery to remove all the cancer spread inside the abdomen
- You are generally active and able to care for yourself, with only minor limitations on strenuous activity (confirm with trial site)
- Your blood cell counts are within an acceptable range — enough white blood cells and platelets
- Your kidneys are working well enough (based on a blood or urine test)
- Your liver is working well enough (based on a blood test)
- If you are a woman who could become pregnant, you have a negative pregnancy test and agree to use effective contraception throughout the study
- If you are a man, you agree to use a reliable barrier method of contraception (such as a condom) for the duration of the study
- You are willing and able to sign a consent form before any study procedures begin
Who may not be able to join:
- You have previously received chemotherapy given directly into the abdomen or through the bloodstream for peritoneal mesothelioma
- You have previously received chemotherapy containing platinum-based drugs (such as cisplatin or carboplatin)
- Your biopsy showed a different subtype of mesothelioma (sarcomatoid, well-differentiated papillary, or benign multicystic)
- You have had another cancer in the past, unless it was certain skin cancers, a fully treated cervical cancer in situ, another cancer with no signs of activity for more than three years, or a very slow-growing cancer being monitored (confirm with trial site)
- There is a strong suspicion the cancer has spread outside the abdomen
- You are pregnant or breastfeeding
- You have active heart artery disease (such as unstable chest pain or a recent abnormal heart stress test) — though those with a history of heart disease may still qualify with a recent normal stress test or a cardiologist's clearance
- You have uncontrolled high blood pressure (above 140/90) that has not been cleared for surgery
- You have moderate-to-severe heart failure or breathing problems that would make participation unsafe or difficult
- You have a history of stroke or other brain blood vessel disease that would make participation unsafe or difficult
- You have other serious health conditions unrelated to your cancer that would make full participation unsafe or difficult
- You have a known allergy to cisplatin, carboplatin, pemetrexed, or mitomycin (chemotherapy drugs used in the trial)
- At the time of surgery, extensive internal scarring (adhesions) prevents chemotherapy from being delivered inside the abdomen
- Any other condition that would prevent the chemotherapy from being safely given inside the abdomen
- You take an oral medication that cannot be substituted and that would be unsafe to stop for up to ten days
- Your life expectancy is estimated to be less than 12 weeks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Garrett Nash, MD, Memorial Sloan Kettering Cancer
Phone: 212-639-8668
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.